Growth/differentiation factor-10 (GDF-10) is a TGF-␤ family member highly related to bone morphogenetic protein-3. In order to determine the biological function of GDF-10, we carried out a detailed analysis of the expression pattern of GDF-10 and characterized GDF-10-null mice that we generated by gene targeting. During embryogenesis GDF-10 is expressed prominently in developing skeletal structures both in the craniofacial region and in the vertebral column. In adult animals, GDF-10 is expressed at high levels in the brain, where GDF-10 is localized primarily to cells in the Purkinje cell layer of the cerebellum, and in the uterus, where the expression levels of GDF-10 are regulated both during the menstrual cycle and during pregnancy. Despite the high levels of GDF-10 expression in these tissues, we found no obvious abnormalities in GDF-10-knockout mice with respect to the development of these tissues. These findings suggest either that GDF-10 plays no regulatory role in these tissues or that its function is redundant with that of other growth factor-like molecules.
INTRODUCTION
Members of the transforming growth factor-␤ (TGF-␤) superfamily play central roles in regulating cell growth and differentiation during development and in adult tissues (for review see McPherron and Lee, 1996) . To date, over 30 mammalian members of the TGF-␤ superfamily have been described. These include the TGF-␤s (Derynck et al., 1985) , bone morphogenetic proteins (BMPs) (Kingsley et al., 1992; Storm et al., 1994; Wozney et al., 1988) , Mü llerian inhibiting substance (Behringer et al., 1990; Cate et al., 1986) , activins and inhibins (Forage et al., 1986; Mason et al., 1985; Mayo et al., 1986) , nodal (Zhou et al., 1993) , lefty (Meno et al., 1996 (Meno et al., , 1998 , TGF-␤-related neurotrophic factors (GDNF (Lin et al., 1993) , neurturin (Horger et al., 1998; Kotzbauer et al., 1996) , and persephin ), and a large, heterogeneous group of proteins termed growth/differentiation factors (GDFs) (Lee, 1991; McGrath et al., 1995; McPherron et al., 1997; McPherron and Lee, 1993) .
The primary structures of all TGF-␤ family members share several common features. Each family member is synthesized as a precursor protein with a signal sequence, an amino-terminal pro-region, and a conserved carboxyterminal domain. The biologically active molecule is believed to be a dimer of C-terminal domains generated by proteolytic cleavage of the precursor protein. The mature carboxy-terminal regions of all family members share some degree of homology at the primary amino acid sequence level and contain six to nine cysteine residues with a characteristic spacing. For several family members for which the three-dimensional structure has been determined (Daopin et al., 1992; Griffith et al., 1996; Mittl et al., 1996; Schlunegger and Grutter, 1992) , it is known that six cysteine residues form three intramolecular disulfide bonds that are arranged in a characteristic cystine knot configuration. Although the C-terminal sequences of all family members are somewhat related, these proteins can be divided into subgroups of highly related factors. Within a given subgroup, factors generally show 70 -90% amino acid sequence identity, whereas between subgroups, the homology generally falls in the range of 20 -50% identity. Growth/differentiation factor-10 (GDF-10) is a new TGF-␤ family member of unknown function. GDF-10 was originally identified by PCR using degenerate oligonucleotides based on the BMP-3 sequence (Cunningham et al., 1995) . Among the known mammalian family members, GDF-10 is most highly related to BMP-3. GDF-10 and BMP-3 show 83% amino acid sequence identity in the C-terminal region and form their own subgroup within the TGF-␤ superfamily. Among a variety of adult tissues screened by Northern analysis, GDF-10 was shown to be expressed at highest levels in uterus, adipose tissue, and brain and at lower levels in liver and spleen. GDF-10 mRNA was also detected in calvarial bone in both neonatal and adult animals. Here we report a detailed characterization of the expression pattern of GDF-10 and an analysis of GDF-10-null mice that we generated by gene targeting. We find that despite the high levels of GDF-10 expression in discrete cell populations during development and in adult tissues, GDF-10 appears to be dispensable for proper development of these cell types.
MATERIALS AND METHODS

Probes and in Situ Hybridization
The amino-terminal coding sequence of GDF-10 was used as a probe for all in situ hybridization experiments in order to avoid possible cross-hybridization with related family members. Brains and embryos were fixed in 4% paraformaldehyde, embedded in paraffin, and sectioned (8 m) using a microtome. Uteri from nonpregnant and 5.5-day-pregnant female mice were frozen in liquid nitrogen and sectioned (10 m) at Ϫ20°C using a cryostat. Riboprobes were prepared with either [
35 S]-or [ 33 P]UTP using a Stratagene in vitro transcription kit. In situ hybridization was carried out as described (Andreasson and Worley, 1995; Wilkinson et al., 1987) . Hybridized sections were exposed to photographic emulsion, developed, and stained with hematoxylin and eosin or toluidine blue.
Northern Analysis
Northern analysis was carried out with 20 g of total RNA (brain samples) or 2 g of twice-poly(A)-selected RNA (uterine samples) as described previously (Lee, 1990) . All uterine RNAs were pooled from four mice except for 18.5-day and labor, which represent a single animal sample. The blots were stripped and hybridized to a tubulin probe as a control for loading.
RNase Protection Assay
Total RNAs were isolated using RNAzol from the uterus of individual female mice. A 320-bp fragment corresponding to the C-terminal region of GDF-10 and a 250-bp fragment from the actin gene were used as probes. The GDF-10 and actin probes were labeled with [ 32 P]UTP and [ 33 P]UTP, respectively, in order to compensate for differences in the abundance of each RNA. Probes were purified on a 5% acrylamide gel with 8 M urea. Five micrograms of total RNA was mixed with 10 5 cpm of each probe and processed using an Ambion RPA kit. Digested probes were separated on a 5% acrylamide gel with 8 M urea. Quantification of signals was carried out using a phosphorimager.
GDF-10-Knockout Mice
The structure of the GDF-10 gene was determined by restriction mapping and partial sequence analysis of phage clones isolated from a 129 Sv/J genomic library. The targeting construct was transfected into R1 embryonic stem cells (kindly provided by A. Nagy, R. Nagy, and W. Abramow-Newerly). Following selection with gancyclovir (2 M) and G418 (250 g/ml), targeted clones identified by Southern analysis were injected into C57BL/6 blastocysts and transferred into pseudopregnant females.
Immunohistochemistry of Cerebellar Sections
Eight-micrometer paraffin cerebellar sections from wild-type, heterozygous, and homozygous mice at 1 week, 2 weeks, 4 months, and 10 months of age were incubated with either monoclonal anti-calbindin (Sigma) or polyclonal anti-GFAP (DAKO) antibodies at a 1:200 or 1:2000 dilution, respectively. Immunohistochemistry was carried out as described (Cartun and Pedersen, 1989) . Sections were counterstained with hematoxylin. For quantification of Purkinje cell densities, five to eight sections were measured for each mouse at10 months of age, and the results from three to five mice for each genotype were combined.
Rotating Wheel Test
GDF-10-homozygous mutant mice and wild-type littermates were tested at the ages of 5 weeks or 2 months. Mice were placed on a stationary wheel, and then the wheel was rotated at 7 rpm. The amount of time that the mouse remained on the wheel was recorded. All the mice were given five trials of practice with 2 min in between, and the results of the sixth trial are contained in Table 1 .
RESULTS
By Northern analysis, GDF-10 was previously shown to be expressed in a wide range of adult tissues, including the brain, uterus, fat, and bone (Cunningham et al., 1995) . To begin to understand the biological functions of GDF-10 in these and other tissues, we carried out a detailed analysis of the expression pattern of GDF-10 in both adult and embryonic tissues.
Expression of GDF-10 during Embryogenesis
To determine whether GDF-10 is expressed during embryogenesis, Northern analysis was carried out using poly(A)-selected RNAs prepared from whole mouse embryos and placentas at various developmental stages. As shown in Fig. 1A , GDF-10 mRNA was detected in embryos at all stages examined from day 8.5 to day 18.5 pc with the highest levels of expression being detected at day 12.5 pc. In contrast, GDF-10 mRNA was not detected in the placenta at any stage examined (Fig. 1B) .
In order to localize sites of GDF-10 expression during embryogenesis, we carried out in situ hybridization to sagittal sections of day 12.5 and day 14.5 pc embryos. For these and all subsequent in situ hybridization experiments, a probe corresponding to the amino-terminal coding region of GDF-10 was used to avoid possible cross-hybridization to related family members, such as BMP-3, whose amino acid sequence in the mature C-terminal region is 83% identical to that of GDF-10. At both day 12.5 and day 14.5 pc, GDF-10 mRNA was primarily localized to developing skeletal structures. The expression of GDF-10 in developing bone was most striking in the axial skeleton, where GDF-10 mRNA was detected in alternating condensations throughout the vertebral column (Figs. 2A, 2B, and 2E). The expression of GDF-10 in developing bone was also observed in the craniofacial region in the developing cartilage of the palate (Fig. 2B ), nasal cavity ( Fig. 2D) , and calvarium in the occipital region (Fig. 2F ). Prominent expression of GDF-10 was also seen in the developing inner ear (Fig. 2C ) as well as in some soft tissues, such as the upper lip ( Fig. 2D ) and lower jaw (data not shown).
Expression of GDF-10 in the Brain
GDF-10 was previously shown to be expressed in adult brain (Cunningham et al., 1995) . In order to identify the regions of the brain in which GDF-10 is expressed, we carried out in situ hybridization analysis of sections prepared from whole mouse brains. From preliminary experiments, we determined that the cerebellum was the predominant site of GDF-10 expression (data not shown). We also confirmed this finding by Northern analysis; as shown in Fig. 3 , GDF-10 mRNA was present at high levels in cerebellum and in whole brain but at very low levels in brains from which the cerebellum had been removed. Therefore, in all subsequent in situ localization experiments, we restricted our analysis to the cerebellum.
As shown in Fig. 4A , GDF-10 mRNA was localized exclusively to the Purkinje cell layer of the cerebellum. At higher magnification, it was clear that the hybridization signal was restricted to small cells surrounding the Purkinje cells but not to the Purkinje cells themselves (Fig. 4B) . To better define these cells expressing GDF-10, we analyzed the pattern of GDF-10 expression at various stages of cerebellar development beginning with newborn mice, in which migration of granule cells had not yet been initiated. As shown in Figs. 4C and 4D, the expression of GDF-10 in newborn mice was detected in a diffuse band of cells below the external granule cell layer. During the first 2 weeks of postnatal development, the expression of GDF-10 mRNA became more intense and focused in the Purkinje cell layer, so that by postnatal day 14, the expression pattern of GDF-10 in the cerebellum closely resembled that of adult animals (Figs. 4E-4L) .
The fact that the GDF-10-expressing cells remained in the vicinity of Purkinje cells throughout cerebellar development rather than undergoing migration as is characteristic of granule cells suggested that these cells were not of 5 weeks 53.0 Ϯ 8.1 (n ϭ 4) 59.0 Ϯ 3.5 (n ϭ 12) 52.3 Ϯ 14.7 (n ϭ 10) 2 months 59.5 Ϯ 1.0 (n ϭ 8) 60.0 Ϯ 0.0 (n ϭ 14) 58.7 Ϯ 2.3 (n ϭ 12) Distance between steps (cm) (2 months) 2.8 Ϯ 0.4 (n ϭ 4) 2.8 Ϯ 0.5 (n ϭ 9) 2.9 Ϯ 0.5 (n ϭ granule cell origin. In order to determine whether the GDF-10-expressing cells represented Bergmann glia, we compared the GDF-10 expression pattern to that obtained by immunohistochemistry using an anti-GFAP antibody, which labels Bergmann glial cells and astrocytes in cerebellum (Schachner et al., 1977) . In the cerebellum, the GFAP antibody detected cell bodies and processes in both the molecular layer and the granule cell layer, but the overall pattern of staining did not appear to overlap with that seen by in situ hybridization using a GDF-10 probe (Fig. 5) . Hence, the GDF-10-expressing cells are unlikely to correspond to Bergmann glia.
Expression of GDF-10 in the Uterus
By Northern analysis, GDF-10 was also shown to be expressed in the uterus of adult mice. In order to understand the role that GDF-10 plays in this tissue, we examined the expression pattern of GDF-10 in the uterus both during pregnancy and during the normal menstrual cycle. As shown in Fig, 6A , the expression levels of GDF-10 were regulated during pregnancy. GDF-10 mRNA appeared to increase immediately after conception, reach peak levels during the first week of pregnancy, and then gradually decrease to barely detectable levels by the end of the gestational period. Immediately following delivery, GDF-10 levels increased dramatically. By in situ hybridization analysis of a day 5.5 pregnant uterus, GDF-10 expression was observed in the proliferating stromal cells between implantation sites but not in the decidualized cells (Fig. 6B) .
We also examined the uterine expression pattern of GDF-10 in nonpregnant animals. By in situ hybridization, GDF-10 appeared to be expressed in the stromal cells but not in the epithelial cells in normal cycling females (Fig.   FIG. 2 . GDF-10 expression in embryos by in situ hybridization. Sections from 12.5-(A, B, C) and 14.5-day (D, E, F) embryos were hybridized to a GDF-10 antisense probe. (A) Low magnification of GDF-10 expression in a 12.5-day embryo. (B-F) Higher magnification of GDF-10 expression in the palate (arrow) and cervical vertebra (arrowhead) (B), inner ear (arrow) (C), upper lip (arrow) and nasal cavity (arrowhead) (D), tail region (arrow) (E), and occipital bone (arrow) (F). 6C). To determine whether the levels of GDF-10 changed during the menstrual cycle, we carried out RNase protection analysis of RNAs prepared from females in which the stage of the menstrual cycle had been assessed by vaginal smears. As shown in Fig. 6E , GDF-10 mRNA was present at relatively high levels during diestrus and early proestrus, when the uterine endometrium is quiescent, and at relatively low levels during estrus and metestrus, when the uterine endometrium is undergoing active proliferation and degeneration.
Generation and Characterization of GDF-10-Null Mice
In order to determine the biological function of GDF-10 in mice, we generated mice in which most of the GDF-10 coding region had been deleted by gene targeting. GDF-10 was originally mapped to the proximal region of mouse chromosome 14 (Cunningham et al., 1995) . We isolated three overlapping genomic clones from a 129 Sv/J genomic library using a GDF-10 probe and determined the structure of the GDF-10 gene using a combination of restriction mapping, Southern analysis, and partial DNA sequencing. As shown in Fig. 7A , the GDF-10 gene consists of three exons spreading over approximately 12 kb. The mature C-terminal region of the GDF-10 protein is encoded in portions of exon 2 and exon 3. In order to ensure that the resulting mice would be null for GDF-10 function, we generated a targeting construct in which the entire second and third exons were replaced with a neo cassette (Fig. 7A) .
The targeting construct was electroporated into R1 embryonic stem (ES) cells, and G418/ganciclovir doubly resistant clones were screened by Southern analysis using a 1-kb probe from outside the targeting construct (Fig. 7A) . From a total of 297 ES cell clones analyzed in this manner, we identified 8 in which the targeting construct had recombined at the GDF-10 locus. Following blastocyst injection of these clones, we obtained one male chimera that transmitted the mutant allele through the germ line. Homozygous mutant mice were obtained from crosses of F1 heterozygotes. In order to confirm that homozygous mice were truly null for GDF-10, we carried out Northern analysis of RNA prepared from the cerebellum of wild-type, heterozygous, and homozygous mice. As shown in Fig. 7B , GDF-10 mRNA was undetectable in the cerebellum of homozygous mutants. Genotypic analysis (Fig. 7C ) of 165 offspring derived from matings of heterozygous mice showed that wild-type, heterozygous, and homozygous GDF-10 mutants were obtained at a ratio close to 1:2:1 (40:77:48). Homozygous mutants were viable and appeared grossly normal. Preliminary histopathological examination of many of the major organs also revealed no obvious abnormalities (data not shown).
Based on the expression pattern of GDF-10 during development and in adult mice, we focused our analysis on those tissues in which the expression of GDF-10 was shown to be the highest. As discussed above, GDF-10 is expressed in developing skeletal structures. In order to determine whether skeletal development was affected by the GDF-10 mutation, we prepared skeletons of wild-type and mutant embryos and mice that had been stained with Alizarin red and Alcian blue. Among 31 homozygous mutants examined, no obvious abnormalities were observed in either the craniofacial region or the axial skeleton (data not shown).
We also carried out a detailed analysis of the cerebellum of homozygous mutants. In order to assess whether cerebellar development was abnormal, we prepared cerebellar sections from wild-type and mutant mice at 1 week, 2 weeks, and 4 months of age. In addition, we examined the cerebellum from 10-month-old animals to look for signs of neuronal degeneration in the mutants. By histological examination, the cerebellum from GDF-10 mutant animals appeared grossly normal and showed the typical organization of the three major cell layers (Fig. 8) . We also performed immunohistochemistry studies using anti-calbindin antibodies to assess Purkinje cell development. At all stages examined, the distribution and number of Purkinje cells in the mutants were indistinguishable from those in wild-type mice (Figs. 8A-8C , 8E, and 8F; Table 1 ). Hence, the development of Purkinje cells appeared to be grossly normal in the mutants, and there appeared to be no significant loss of Purkinje cells as the animals aged. Similarly, immunohistochemical analysis using anti-GFAP antibodies revealed no obvious differences in glial cells between wild-type and mutant animals (Fig. 8D) .
In order to test cerebellar function in the mutants, we carried out two tests to assess balance and motor control. First, we examined their gaits. The gaits of mutant mice appeared normal, and measurement of the distance between steps revealed no differences between wild-type and mutant animals (Table 1) . Second, we subjected the mice to the rotating rod test. As shown in Table 1 , the ability of mutant animals to remain on the rotating rod was comparable to that of wild-type and heterozygous mice.
Finally, because GDF-10 is expressed at high levels in the uterus, we examined the reproductive function of mutant females. An analysis of the estrous cycle determined by daily serial vaginal smears over a period of 12 days showed no differences between wild type and homozygous mutants with respect to the average length of the cycle (Table 1) . The fertility of GDF-10 homozygous mutants was also comparable to that of wild-type mice by a variety of criteria. As shown in Table 1 , the frequency with which the animals became pregnant (relative to the frequency of vaginal plugs), the gestational length, and the litter size were all similar between wild-type and homozygous mutant mice.
DISCUSSION
GDF-10 was originally identified in a screen for novel TGF-␤ family members using a degenerate PCR strategy (Cunningham et al., 1995) . Among the known TGF-␤ family members, GDF-10 is most highly related to BMP-3. GDF-10 and BMP-3 are 83% identical in the mature C-terminal region and form their own distinct subgroup within the TGF-␤ superfamily. GDF-10 was previously shown to be expressed at high levels in several adult tissues, but the biological function of GDF-10 is unknown. In this report, we have provided a detailed analysis of the expression pattern of GDF-10 in both embryonic and adult tissues and a characterization of GDF-10-null mice that we generated by gene targeting.
We have shown that during embryonic development, GDF-10 is expressed most prominently in developing skeletal structures. In this respect, a number of known TGF-␤ family members have been shown to play important roles in regulating skeletal development. In fact, the bone morphogenetic proteins were originally identified for their ability to induce de novo endochondral bone formation when implanted subcutaneously or intramuscularly into rodents (Wozney et al., 1988) , and several TGF-␤ family members have been shown to be essential for proper skeletal development in mice. For example, mutations in BMP-5 result in a variety of skeletal defects affecting the external ears, sternum, ribs, and vertebrae (King et al., 1994) , and mutations in GDF-5 lead to defects in the development of long bones and digits (Storm et al., 1994) . The expression pattern of GDF-10 and the high degree of homology between GDF-10 and BMP-3 suggest that GDF-10 may also be involved in regulating cartilage and/or bone development.
We have also examined the expression pattern of GDF-10 in adult tissues. In the brain, GDF-10 is expressed at highest levels in the cerebellum, where the expression of GDF-10 is highly localized to small cells in the Purkinje cell layer. Based on an analysis of GDF-10 expression during cerebellar development as well as immunohistochemical studies, it appears that the GDF-10-expressing cells are not Purkinje cells, granule cells, or Bergmann glial cells. The distribution of the GDF-10-expressing cells also does not correspond to the known distribution of either basket cells or stellate cells (Altman, 1972) . One other cerebellar cell type, the Lugaro cell, has been reported to reside in the Purkinje cell layer (Sahin and Hockfield, 1990) . However, the ratio of Lugaro cells to Purkinje cells has been reported to be approximately 1:20, and our experiments indicate that the GDF-10-expressing cells appear to be more abundant than Purkinje cells. Hence, the GDF-10-expressing cells are unlikely to represent Lugaro cells and most likely represent a subpopulation of cells for which specific morphologic characteristics or molecular makers have not yet been identified.
The expression pattern of GDF-10 in the cerebellum suggests that GDF-10 plays a role in regulating cerebellar development or function, perhaps of the Purkinje cells themselves. Indeed, other members of the TGF-␤ family, including several BMPs, activin, TGF-␤, GDF-7, GDNF, neurturin, and persephin, have been shown to be important regulators of neuronal survival and differentiation. In fact, GDNF has been shown to be capable of promoting the survival and differentiation of Purkinje cells in dissociated cultures of embryonic rat cerebellum (Mount et al., 1995) and rescuing loss of Purkinje cells induced by ethanol in explant cultures of developing cerebellum (McAlhany et al., 1997) . It will be important to determine whether GDF-10 has a similar biological activity in vitro.
In the uterus, GDF-10 was found to be expressed in the stromal cells but not in the epithelial cells. We also showed that the expression levels of GDF-10 in the uterus are regulated both during pregnancy and during the normal (B) Northern analysis of GDF-10 expression in the cerebellum of wild-type, heterozygous, and homozygous mutant mice. (C) Southern analysis of knockout mice. Mice 1 and 3 are F1 heterozygous mice, and mice 18 -27 are F2 offspring derived from a mating of mice 1 and 3. Genomic DNAs were digested with BamHI, and expected fragments for wild-type and targeted alleles were 21 and 19 kb, respectively. menstrual cycle. During pregnancy, the expression levels of GDF-10 were highest during the early stages and gradually decreased until birth. During the menstrual cycle, the expression levels of GDF-10 were highest during diestrus and early proestrus. While an autocrine or paracrine role for GDF-10 in regulating either stromal cell or epithelial cell growth seems most likely, an elucidation of specific biological function of GDF-10 in the uterus will require an analysis of the effects of GDF-10 in vitro and a determination of the distribution of GDF-10 receptors.
Whatever biological functions GDF-10 may carry out in these and other tissues, the GDF-10-knockout mice appear to be relatively normal in terms of the development of the tissues in which GDF-10 is expressed at highest levels. In particular, to the extent that we have examined, the development of the skeleton and cerebellum as well as female reproductive function all appear to be indistinguishable between wild-type and GDF-10 mutant animals. It is certainly possible that the GDF-10 mutant animals have some subtle defects that were not uncovered in our analysis or that these mutants have phenotypes that are not apparent under standard laboratory conditions. Alternatively, it is possible that the loss of GDF-10 function is compensated by other growth factor-like molecules in the mutant mice. In this regard, a likely candidate for a molecule that may have biological activities similar to those of GDF-10 is BMP-3. In vivo, BMP-3 has been shown to be expressed in a wide range of tissues (Takahashi and Ikeda, 1996) , including some in which GDF-10 is expressed. Clearly, an understanding of the biological function of GDF-10 will await an analysis of the phenotype of mice lacking both GDF-10 and BMP-3 FIG. 8. Immunohistochemical analysis of cerebellar sections from GDF-10-knockout and -heterozygous mice at 1 week (A), 2 weeks (B), 4 months (C, D), and 10 months (E, F) of age. Anti-calbindin antibodies were used for all experiments except for those shown in D, in which anti-GFAP antibodies were used.
